Identification of Pax5 as a Target of MTA1 in B-Cell Lymphomas

Cancer Research - United States
doi 10.1158/0008-5472.can-07-0750
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Alternative Splicing of the Trout Pax5 Gene and Identification of Novel B Cell Populations Using Pax5 Signatures

Developmental and Comparative Immunology
ImmunologyDevelopmental Biology
2013English

Proteomics Based Identification of Proteins With Deregulated Expression in B Cell Lymphomas

PLoS ONE
Multidisciplinary
2016English

Liposomes Modified by Carbohydrate Ligands Can Target B Cells for the Treatment of B-Cell Lymphomas

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2010English

Cell Cycle Deregulation in B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Double-Hit B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Lenalidomide in Diffuse Large B-Cell Lymphomas

Advances in Hematology
Hematology
2012English

CDC37 as a Novel Target for the Treatment of NPM1-ALK Expressing Anaplastic Large Cell Lymphomas

Blood Cancer Journal
OncologyHematology
2019English

Identification of ADGRE5 as Discriminating MYC Target Between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Pretargeted Radioimmunotherapy for B-Cell Lymphomas

Clinical Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy